Balibey, H. Et Al. 2011. CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.21, no.2 , 93-99.

Balibey, H., Basoglu, C., Lundgren, S., BABAOĞLU, M. Ö., YAŞAR, Ü., Herken, H., ... Rane, A.(2011). CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.21, no.2, 93-99.

Balibey, Hakan Et Al. "CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia," KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.21, no.2, 93-99, 2011

Balibey, Hakan Et Al. "CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia." KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.21, no.2, pp.93-99, 2011

Balibey, H. Et Al. (2011) . "CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia." KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , vol.21, no.2, pp.93-99.

@article{article, author={Hakan Balibey Et Al. }, title={CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia}, journal={KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY}, year=2011, pages={93-99} }